Coya: Outstanding Data In ALS And Alzheimer's Justify Large Upside
Seeking Alpha,
Summary Recently, IPO’d Coya has just reported cognition-improving and cognition-stabilizing results in an open label study in…
Summary Recently, IPO’d Coya has just reported cognition-improving and cognition-stabilizing results in an open label study in…
HOUSTON, TX / ACCESSWIRE / April 14, 2023 / In many ways, Alzheimer's disease (AD) remains a mystery.
HOUSTON, TX / ACCESSWIRE / April 14, 2023 / In many ways, Alzheimer's disease (AD) remains a mystery.